HEADER HYDROLASE/HYDROLASE INHIBITOR 26-JUL-95 1LMW
TITLE LMW U-PA STRUCTURE COMPLEXED WITH EGRCMK (GLU-GLY-ARG CHLOROMETHYL
TITLE 2 KETONE)
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: UROKINASE-TYPE PLASMINOGEN ACTIVATOR;
COMPND 3 CHAIN: A, C;
COMPND 4 SYNONYM: LMW U-PA;
COMPND 5 EC: 3.4.21.73;
COMPND 6 ENGINEERED: YES;
COMPND 7 MOL_ID: 2;
COMPND 8 MOLECULE: UROKINASE-TYPE PLASMINOGEN ACTIVATOR;
COMPND 9 CHAIN: B, D;
COMPND 10 SYNONYM: LMW U-PA;
COMPND 11 EC: 3.4.21.73;
COMPND 12 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 7 MOL_ID: 2;
SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 9 ORGANISM_COMMON: HUMAN;
SOURCE 10 ORGANISM_TAXID: 9606;
SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS FIBRINOLYSIS, TRYPSIN-LIKE SERINE PROTEASE, SERINE PROTEASE,
KEYWDS 2 HYDROLASE-HYDROLASE INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR G.S.SPRAGGON,C.PHILLIPS,U.K.NOWAK,C.P.PONTING,D.SAUNDERS,C.M.DOBSON,
AUTHOR 2 D.I.STUART,E.Y.JONES
REVDAT 5 30-OCT-24 1LMW 1 REMARK LINK
REVDAT 4 13-JUL-11 1LMW 1 VERSN
REVDAT 3 24-FEB-09 1LMW 1 VERSN
REVDAT 2 01-APR-03 1LMW 1 JRNL
REVDAT 1 29-JAN-96 1LMW 0
JRNL AUTH G.SPRAGGON,C.PHILLIPS,U.K.NOWAK,C.P.PONTING,D.SAUNDERS,
JRNL AUTH 2 C.M.DOBSON,D.I.STUART,E.Y.JONES
JRNL TITL THE CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN
JRNL TITL 2 UROKINASE-TYPE PLASMINOGEN ACTIVATOR.
JRNL REF STRUCTURE V. 3 681 1995
JRNL REFN ISSN 0969-2126
JRNL PMID 8591045
JRNL DOI 10.1016/S0969-2126(01)00203-9
REMARK 2
REMARK 2 RESOLUTION. 2.50 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : X-PLOR
REMARK 3 AUTHORS : BRUNGER
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL
REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 NUMBER OF REFLECTIONS : 15684
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : NULL
REMARK 3 FREE R VALUE TEST SET SELECTION : NULL
REMARK 3 R VALUE (WORKING SET) : 0.224
REMARK 3 FREE R VALUE : NULL
REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT : NULL
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : NULL
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL
REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL
REMARK 3 BIN R VALUE (WORKING SET) : NULL
REMARK 3 BIN FREE R VALUE : NULL
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 4043
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 50
REMARK 3 SOLVENT ATOMS : 0
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM SIGMAA (A) : NULL
REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM C-V SIGMAA (A) : NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.013
REMARK 3 BOND ANGLES (DEGREES) : NULL
REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL
REMARK 3 IMPROPER ANGLES (DEGREES) : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : NULL
REMARK 3 TOPOLOGY FILE 1 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS:
REMARK 3 THE 23 RESIDUES OF THE SHORT A CHAIN IN EACH SUBUNIT ARE
REMARK 3 HIGHLY MOBILE. RESIDUES 147 - 152 (1 - 6 AS CHYMOTRYPSIN
REMARK 3 EQUIVALENTS) ARE MODELED IN DENSITY, 153 AND 154 FITTED
REMARK 3 TENTATIVELY IN WEAK DENSITY WHILE THE REMAINDER ARE ABSENT.
REMARK 4
REMARK 4 1LMW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.
REMARK 100 THE DEPOSITION ID IS D_1000174767.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 1994
REMARK 200 TEMPERATURE (KELVIN) : NULL
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : NULL
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : PHOTON FACTORY
REMARK 200 BEAMLINE : BL-6A
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : NULL
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : FUJI
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200 DATA SCALING SOFTWARE : NULL
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15684
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500
REMARK 200 RESOLUTION RANGE LOW (A) : 30.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 70.0
REMARK 200 DATA REDUNDANCY : 3.500
REMARK 200 R MERGE (I) : 0.11100
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: NULL
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL
REMARK 200 SOFTWARE USED: X-PLOR
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 52.50
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.59
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: NULL
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -Y,X-Y,Z
REMARK 290 3555 -X+Y,-X,Z
REMARK 290 4555 X+2/3,Y+1/3,Z+1/3
REMARK 290 5555 -Y+2/3,X-Y+1/3,Z+1/3
REMARK 290 6555 -X+Y+2/3,-X+1/3,Z+1/3
REMARK 290 7555 X+1/3,Y+2/3,Z+2/3
REMARK 290 8555 -Y+1/3,X-Y+2/3,Z+2/3
REMARK 290 9555 -X+Y+1/3,-X+2/3,Z+2/3
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 88.35000
REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 51.00890
REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 18.13333
REMARK 290 SMTRY1 5 -0.500000 -0.866025 0.000000 88.35000
REMARK 290 SMTRY2 5 0.866025 -0.500000 0.000000 51.00890
REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 18.13333
REMARK 290 SMTRY1 6 -0.500000 0.866025 0.000000 88.35000
REMARK 290 SMTRY2 6 -0.866025 -0.500000 0.000000 51.00890
REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 18.13333
REMARK 290 SMTRY1 7 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 102.01779
REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 36.26667
REMARK 290 SMTRY1 8 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 8 0.866025 -0.500000 0.000000 102.01779
REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 36.26667
REMARK 290 SMTRY1 9 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 9 -0.866025 -0.500000 0.000000 102.01779
REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 36.26667
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 820 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 12080 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 980 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 11960 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 400
REMARK 400 COMPOUND
REMARK 400 THE STRUCTURE IS THAT OF THE ACTIVE, TWO CHAIN FORM OF
REMARK 400 THE ENZYME.
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 LYS A -11
REMARK 465 PRO A -10
REMARK 465 SER A -9
REMARK 465 SER A -8
REMARK 465 PRO A -7
REMARK 465 PRO A -6
REMARK 465 GLU A -5
REMARK 465 GLU A -4
REMARK 465 LEU A -3
REMARK 465 LYS A -2
REMARK 465 PHE A -1
REMARK 465 GLN A 0
REMARK 465 PHE A 10
REMARK 465 LYS A 11
REMARK 465 ASN B 246
REMARK 465 GLY B 247
REMARK 465 LEU B 248
REMARK 465 ALA B 249
REMARK 465 LEU B 250
REMARK 465 LYS C -11
REMARK 465 PRO C -10
REMARK 465 SER C -9
REMARK 465 SER C -8
REMARK 465 PRO C -7
REMARK 465 PRO C -6
REMARK 465 GLU C -5
REMARK 465 GLU C -4
REMARK 465 LEU C -3
REMARK 465 LYS C -2
REMARK 465 PHE C -1
REMARK 465 GLN C 0
REMARK 465 ARG C 9
REMARK 465 PHE C 10
REMARK 465 LYS C 11
REMARK 465 ASN D 246
REMARK 465 GLY D 247
REMARK 465 LEU D 248
REMARK 465 ALA D 249
REMARK 465 LEU D 250
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 ARG A 9 CA C O CB CG CD NE
REMARK 470 ARG A 9 CZ NH1 NH2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 OG SER B 195 O2 0GJ B 1 1.95
REMARK 500 OG SER D 195 O2 0GJ D 1 2.00
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS
REMARK 500
REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC
REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15
REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A
REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375
REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE
REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS.
REMARK 500
REMARK 500 DISTANCE CUTOFF:
REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS
REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE
REMARK 500 OE2 GLU D 110B NH2 ARG D 206 5655 1.72
REMARK 500 O TYR B 127 NE ARG D 166 6675 1.76
REMARK 500 CB TYR B 127 NH2 ARG D 166 6675 1.96
REMARK 500 CB TYR B 127 CZ ARG D 166 6675 1.97
REMARK 500 CA TYR B 127 NH2 ARG D 166 6675 1.98
REMARK 500 CB TYR B 127 NE ARG D 166 6675 1.98
REMARK 500 O TYR B 127 CD ARG D 166 6675 2.11
REMARK 500 CD2 HIS B 37 NH2 ARG B 116 3675 2.17
REMARK 500 C TYR B 127 NE ARG D 166 6675 2.18
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 GLY B 37C N - CA - C ANGL. DEV. = 15.5 DEGREES
REMARK 500 PRO B 60C C - N - CA ANGL. DEV. = 10.4 DEGREES
REMARK 500 LEU B 150 CA - CB - CG ANGL. DEV. = 14.0 DEGREES
REMARK 500 PRO B 198 C - N - CA ANGL. DEV. = 18.4 DEGREES
REMARK 500 PRO B 198 C - N - CD ANGL. DEV. = -15.9 DEGREES
REMARK 500 PRO B 198 N - CA - C ANGL. DEV. = 16.3 DEGREES
REMARK 500 LEU B 199 N - CA - C ANGL. DEV. = -20.2 DEGREES
REMARK 500 PRO D 60C C - N - CA ANGL. DEV. = 12.0 DEGREES
REMARK 500 LEU D 199 N - CA - C ANGL. DEV. = -18.0 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 THR A 5 159.91 -46.29
REMARK 500 GLU B 20 76.55 -177.39
REMARK 500 THR B 22 -156.87 -132.40
REMARK 500 ILE B 24 16.40 -66.38
REMARK 500 PRO B 28 -12.05 -45.02
REMARK 500 SER B 37D -167.30 -64.81
REMARK 500 VAL B 41 -82.42 -83.99
REMARK 500 MET B 47 -50.90 -124.98
REMARK 500 SER B 54 -137.79 -115.69
REMARK 500 HIS B 57 4.65 -63.05
REMARK 500 ILE B 60 -86.33 -57.12
REMARK 500 PRO B 60C 23.77 -71.90
REMARK 500 ASP B 63 34.85 -91.34
REMARK 500 LEU B 73 -82.97 -57.17
REMARK 500 ASN B 74 47.96 -91.65
REMARK 500 ASN B 87 109.02 -172.38
REMARK 500 LEU B 90 -168.62 -105.34
REMARK 500 LYS B 92 11.97 -56.91
REMARK 500 ASP B 97 -156.22 -112.59
REMARK 500 THR B 97A 20.31 -72.58
REMARK 500 LEU B 97B -59.29 -165.27
REMARK 500 ASP B 102 92.37 -67.14
REMARK 500 GLN B 113 58.32 -113.71
REMARK 500 PRO B 114 117.49 -23.73
REMARK 500 ARG B 116 -53.38 -21.68
REMARK 500 ILE B 118 91.96 -68.63
REMARK 500 SER B 125 -159.44 -76.52
REMARK 500 TYR B 127 39.96 19.12
REMARK 500 PRO B 130 177.91 -52.11
REMARK 500 PHE B 141 30.33 -80.77
REMARK 500 ASN B 145 132.32 -172.74
REMARK 500 ASP B 148 164.14 -49.55
REMARK 500 TYR B 149 -3.19 -140.12
REMARK 500 PRO B 152 144.79 -30.55
REMARK 500 LEU B 155 142.37 -37.53
REMARK 500 MET B 157 149.96 -170.43
REMARK 500 TYR B 171 -126.92 -104.79
REMARK 500 PRO B 185A -54.68 -25.80
REMARK 500 GLN B 185B 123.34 177.78
REMARK 500 TRP B 186 7.03 58.78
REMARK 500 ASP B 189 176.90 179.39
REMARK 500 SER B 190 -156.74 -99.21
REMARK 500 CYS B 191 -172.90 178.58
REMARK 500 SER B 195 152.55 -41.05
REMARK 500 PRO B 198 118.83 -24.36
REMARK 500 GLN B 204 14.67 56.93
REMARK 500 SER B 214 -47.89 -136.47
REMARK 500 ALA B 221 95.39 53.00
REMARK 500 PRO B 225 -169.18 -61.11
REMARK 500 LYS B 243 -65.42 -91.39
REMARK 500
REMARK 500 THIS ENTRY HAS 91 RAMACHANDRAN OUTLIERS.
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: PLANAR GROUPS
REMARK 500
REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL
REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE
REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN
REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS
REMARK 500 AN RMSD GREATER THAN THIS VALUE
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 M RES CSSEQI RMS TYPE
REMARK 500 HIS D 57 0.09 SIDE CHAIN
REMARK 500
REMARK 500 REMARK: NULL
REMARK 600
REMARK 600 HETEROGEN
REMARK 600
REMARK 600 THE UNBOUND FORM OF THE INHIBITOR IS GLU-GLY-ARG-
REMARK 600 CHLOROMETHYLKETONE. UPON REACTION WITH PROTEIN IT FORMS TWO
REMARK 600 COVALENT BONDS: 1) A COVALENT BOND TO OG SER 195 FORMING A
REMARK 600 HEMIKETAL AR7 AND 2) A COVALENT BOND TO NE2 OF HIS 57
REMARK 630
REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR
REMARK 630 MOLECULE NAME: L-ALPHA-GLUTAMYL-N-{(1S)-4-{[AMINO(IMINIO)METHYL]
REMARK 630 AMINO}-1-[(1S)-2-CHLORO-1-HYDROXYETHYL]BUTYL}GLYCINAMIDE
REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 630
REMARK 630 M RES C SSSEQI
REMARK 630 0GJ B 1
REMARK 630 0GJ D 1
REMARK 630 SOURCE: NULL
REMARK 630 TAXONOMY: NULL
REMARK 630 SUBCOMP: GLU GLY AR7 0QE
REMARK 630 DETAILS: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0GJ B 1
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0GJ D 1
REMARK 999
REMARK 999 SEQUENCE
REMARK 999 THE RESIDUES IN THE STRUCTURE ARE NUMBERED, AS IS
REMARK 999 CONVENTIONAL WITH SERINE PROTEASES, AS TOPOLOGICAL
REMARK 999 EQUIVALENTS TO CHYMOTRYPSIN.
DBREF 1LMW A -11 11 UNP P00749 UROK_HUMAN 156 178
DBREF 1LMW B 16 250 UNP P00749 UROK_HUMAN 179 431
DBREF 1LMW C -11 11 UNP P00749 UROK_HUMAN 156 178
DBREF 1LMW D 16 250 UNP P00749 UROK_HUMAN 179 431
SEQRES 1 A 23 LYS PRO SER SER PRO PRO GLU GLU LEU LYS PHE GLN CYS
SEQRES 2 A 23 GLY GLN LYS THR LEU ARG PRO ARG PHE LYS
SEQRES 1 B 253 ILE ILE GLY GLY GLU PHE THR THR ILE GLU ASN GLN PRO
SEQRES 2 B 253 TRP PHE ALA ALA ILE TYR ARG ARG HIS ARG GLY GLY SER
SEQRES 3 B 253 VAL THR TYR VAL CYS GLY GLY SER LEU MET SER PRO CYS
SEQRES 4 B 253 TRP VAL ILE SER ALA THR HIS CYS PHE ILE ASP TYR PRO
SEQRES 5 B 253 LYS LYS GLU ASP TYR ILE VAL TYR LEU GLY ARG SER ARG
SEQRES 6 B 253 LEU ASN SER ASN THR GLN GLY GLU MET LYS PHE GLU VAL
SEQRES 7 B 253 GLU ASN LEU ILE LEU HIS LYS ASP TYR SER ALA ASP THR
SEQRES 8 B 253 LEU ALA HIS HIS ASN ASP ILE ALA LEU LEU LYS ILE ARG
SEQRES 9 B 253 SER LYS GLU GLY ARG CYS ALA GLN PRO SER ARG THR ILE
SEQRES 10 B 253 GLN THR ILE CYS LEU PRO SER MET TYR ASN ASP PRO GLN
SEQRES 11 B 253 PHE GLY THR SER CYS GLU ILE THR GLY PHE GLY LYS GLU
SEQRES 12 B 253 ASN SER THR ASP TYR LEU TYR PRO GLU GLN LEU LYS MET
SEQRES 13 B 253 THR VAL VAL LYS LEU ILE SER HIS ARG GLU CYS GLN GLN
SEQRES 14 B 253 PRO HIS TYR TYR GLY SER GLU VAL THR THR LYS MET LEU
SEQRES 15 B 253 CYS ALA ALA ASP PRO GLN TRP LYS THR ASP SER CYS GLN
SEQRES 16 B 253 GLY ASP SER GLY GLY PRO LEU VAL CYS SER LEU GLN GLY
SEQRES 17 B 253 ARG MET THR LEU THR GLY ILE VAL SER TRP GLY ARG GLY
SEQRES 18 B 253 CYS ALA LEU LYS ASP LYS PRO GLY VAL TYR THR ARG VAL
SEQRES 19 B 253 SER HIS PHE LEU PRO TRP ILE ARG SER HIS THR LYS GLU
SEQRES 20 B 253 GLU ASN GLY LEU ALA LEU
SEQRES 1 C 23 LYS PRO SER SER PRO PRO GLU GLU LEU LYS PHE GLN CYS
SEQRES 2 C 23 GLY GLN LYS THR LEU ARG PRO ARG PHE LYS
SEQRES 1 D 253 ILE ILE GLY GLY GLU PHE THR THR ILE GLU ASN GLN PRO
SEQRES 2 D 253 TRP PHE ALA ALA ILE TYR ARG ARG HIS ARG GLY GLY SER
SEQRES 3 D 253 VAL THR TYR VAL CYS GLY GLY SER LEU MET SER PRO CYS
SEQRES 4 D 253 TRP VAL ILE SER ALA THR HIS CYS PHE ILE ASP TYR PRO
SEQRES 5 D 253 LYS LYS GLU ASP TYR ILE VAL TYR LEU GLY ARG SER ARG
SEQRES 6 D 253 LEU ASN SER ASN THR GLN GLY GLU MET LYS PHE GLU VAL
SEQRES 7 D 253 GLU ASN LEU ILE LEU HIS LYS ASP TYR SER ALA ASP THR
SEQRES 8 D 253 LEU ALA HIS HIS ASN ASP ILE ALA LEU LEU LYS ILE ARG
SEQRES 9 D 253 SER LYS GLU GLY ARG CYS ALA GLN PRO SER ARG THR ILE
SEQRES 10 D 253 GLN THR ILE CYS LEU PRO SER MET TYR ASN ASP PRO GLN
SEQRES 11 D 253 PHE GLY THR SER CYS GLU ILE THR GLY PHE GLY LYS GLU
SEQRES 12 D 253 ASN SER THR ASP TYR LEU TYR PRO GLU GLN LEU LYS MET
SEQRES 13 D 253 THR VAL VAL LYS LEU ILE SER HIS ARG GLU CYS GLN GLN
SEQRES 14 D 253 PRO HIS TYR TYR GLY SER GLU VAL THR THR LYS MET LEU
SEQRES 15 D 253 CYS ALA ALA ASP PRO GLN TRP LYS THR ASP SER CYS GLN
SEQRES 16 D 253 GLY ASP SER GLY GLY PRO LEU VAL CYS SER LEU GLN GLY
SEQRES 17 D 253 ARG MET THR LEU THR GLY ILE VAL SER TRP GLY ARG GLY
SEQRES 18 D 253 CYS ALA LEU LYS ASP LYS PRO GLY VAL TYR THR ARG VAL
SEQRES 19 D 253 SER HIS PHE LEU PRO TRP ILE ARG SER HIS THR LYS GLU
SEQRES 20 D 253 GLU ASN GLY LEU ALA LEU
HET 0GJ B 1 25
HET 0GJ D 1 25
HETNAM 0GJ L-ALPHA-GLUTAMYL-N-{(1S)-4-{[AMINO(IMINIO)
HETNAM 2 0GJ METHYL]AMINO}-1-[(1S)-2-CHLORO-1-
HETNAM 3 0GJ HYDROXYETHYL]BUTYL}GLYCINAMIDE
FORMUL 5 0GJ 2(C14 H28 CL N6 O5 1+)
HELIX 1 1 THR B 56 CYS B 58 5 3
HELIX 2 2 HIS B 165 CYS B 168 1 4
HELIX 3 3 GLY B 173 GLU B 175 5 3
HELIX 4 4 VAL B 231 THR B 242 5 12
HELIX 5 6 VAL B 231 HIS B 241 1 11
SHEET 1 A 6 TRP B 51 SER B 54 0
SHEET 2 A 6 ALA B 104 SER B 110 -1 N LEU B 106 O VAL B 52
SHEET 3 A 6 MET B 81 ILE B 89 -1 N ILE B 89 O LEU B 105
SHEET 4 A 6 TYR B 64 LEU B 68 -1 N LEU B 68 O MET B 81
SHEET 5 A 6 ALA B 31 ARG B 36 -1 N TYR B 34 O ILE B 65
SHEET 6 A 6 VAL B 38 CYS B 42 -1 N CYS B 42 O ILE B 33
SHEET 1 B 4 SER B 135 GLY B 140 0
SHEET 2 B 4 LYS B 156 ILE B 163 -1 N VAL B 160 O CYS B 136
SHEET 3 B 4 MET B 180 ALA B 184 -1 N ALA B 184 O LYS B 161
SHEET 4 B 4 GLY B 226 THR B 229 -1 N TYR B 228 O LEU B 181
SHEET 1 C 6 VAL D 38 TYR D 40 0
SHEET 2 C 6 ALA D 31 ARG D 36 -1 N ARG D 35 O THR D 39
SHEET 3 C 6 TYR D 64 LEU D 68 -1 N TYR D 67 O ALA D 32
SHEET 4 C 6 MET D 81 LEU D 88 -1 N PHE D 83 O VAL D 66
SHEET 5 C 6 ALA D 104 SER D 110 -1 N ARG D 109 O GLU D 84
SHEET 6 C 6 TRP D 51 SER D 54 -1 N SER D 54 O ALA D 104
SHEET 1 D 6 SER D 135 GLY D 140 0
SHEET 2 D 6 LYS D 156 ILE D 163 -1 N VAL D 160 O CYS D 136
SHEET 3 D 6 MET D 180 ALA D 184 -1 N ALA D 184 O LYS D 161
SHEET 4 D 6 GLY D 226 ARG D 230 -1 N TYR D 228 O LEU D 181
SHEET 5 D 6 ARG D 206 TRP D 215 -1 N TRP D 215 O VAL D 227
SHEET 6 D 6 PRO D 198 LEU D 203 -1 N LEU D 203 O ARG D 206
SHEET 1 E 2 PRO B 198 LEU B 203 0
SHEET 2 E 2 ARG B 206 ILE B 212 -1 N GLY B 211 O LEU B 199
SSBOND 1 CYS A 1 CYS B 122 1555 1555 2.05
SSBOND 2 CYS B 42 CYS B 58 1555 1555 2.04
SSBOND 3 CYS B 50 CYS B 111 1555 1555 2.03
SSBOND 4 CYS B 136 CYS B 201 1555 1555 2.03
SSBOND 5 CYS B 168 CYS B 182 1555 1555 2.03
SSBOND 6 CYS B 191 CYS B 220 1555 1555 2.02
SSBOND 7 CYS C 1 CYS D 122 1555 1555 2.05
SSBOND 8 CYS D 42 CYS D 58 1555 1555 2.03
SSBOND 9 CYS D 50 CYS D 111 1555 1555 2.03
SSBOND 10 CYS D 136 CYS D 201 1555 1555 2.05
SSBOND 11 CYS D 168 CYS D 182 1555 1555 2.04
SSBOND 12 CYS D 191 CYS D 220 1555 1555 2.03
LINK C3 0GJ B 1 NE2 HIS B 57 1555 1555 1.48
LINK C2 0GJ B 1 OG SER B 195 1555 1555 1.47
LINK C3 0GJ D 1 NE2 HIS D 57 1555 1555 1.57
LINK C2 0GJ D 1 OG SER D 195 1555 1555 1.44
SITE 1 AC1 14 HIS B 57 LEU B 97B HIS B 99 ASP B 189
SITE 2 AC1 14 SER B 190 GLN B 192 GLY B 193 SER B 195
SITE 3 AC1 14 SER B 214 TRP B 215 GLY B 216 ARG B 217
SITE 4 AC1 14 GLY B 218 CYS B 220
SITE 1 AC2 15 HIS D 57 LEU D 97B HIS D 99 ASP D 189
SITE 2 AC2 15 CYS D 191 GLN D 192 GLY D 193 SER D 195
SITE 3 AC2 15 SER D 214 TRP D 215 GLY D 216 ARG D 217
SITE 4 AC2 15 GLY D 218 CYS D 220 GLY D 226
CRYST1 176.700 176.700 54.400 90.00 90.00 120.00 H 3 18
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.005659 0.003267 0.000000 0.00000
SCALE2 0.000000 0.006535 0.000000 0.00000
SCALE3 0.000000 0.000000 0.018382 0.00000